The global nucleotide industry recorded sales of USD 594.2 million in 2022. The industry experienced a 6.4% year-on-year growth in 2023 and is anticipated to achieve a value of USD 672.5 million in 2024. Over the assessment period from 2024 to 2034, the global sector is projected to expand at a compound annual growth rate (CAGR) of 6.1%, resulting in a valuation of USD 1,205.4 million by the end of 2034.
The robust upward trajectory of growth of the business space is propelled by the expansion of the biotechnology sector and the new cutting-edge technologies. The biomedical research field has undergone a significant rise in genomic and customized medicine studies, thus leading to a major appeal for superior-quality nucleotides.
Polymerase chain reaction and gene sequencing, along with other molecular diagnostic techniques, are crucial applications that require the use of these molecules for RNA and DNA synthesis.
As these constitute the building blocks for genetic material, they have become valuable in the pharmaceutical industry. These play a vital role in the formulation of novel antiviral drugs and cancer treatments. The need to fight viral infections alongside a continuous search for improved oncological therapies has prompted pharmaceutical enterprises to depend heavily on nucleotides.
In addition, global health crises have heightened attention to fast diagnostic tests and effective treatment methods, thus raising demand for these further. This demand is not just limited to human healthcare but extends to veterinary applications, contributing to the overall market growth.
| Attributes | Description |
|---|---|
| Estimated Global Nucleotide Size (2024E) | USD 672.5 million |
| Projected Global Nucleotide Value (2034F) | USD 1,205.4 million |
| Value-based CAGR (2024 to 2034) | 6.1% |
Advancement in technology related to nucleotide synthesis and extraction has considerably reduced entry barriers hence making these vital bio-materials more accessible and affordable. Methods that include highly efficient chemical synthesis approaches or improved enzymatic production protocols lead to cost reduction.
Consequently, this democratization now allows them to be found in a range of industries like pharmaceuticals or food technology. When nucleotides are cost-effective, they attract many different product and service integrations where they were not needed before. Their increased use across industries signifies the democratization of their application from pharmaceuticals down to food technology sectors respectively as it becomes more cost-effective.
This broadened scope of application has facilitated deeper industry penetration, particularly into sectors constrained by the previously expensive nature of these molecules thereby resulting in an increase in sales volume through increased applications across its value chains including health supplements products up to advanced research tools including diagnostics.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2023) and current year (2024) for the global market.
This analysis reveals crucial shifts in performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the sales growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 4.5% (2023 to 2033) |
| H2 | 5.1% (2023 to 2033) |
| H1 | 5.4% (2024 to 2034) |
| H2 | 6.4% (2024 to 2034) |
In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 4.5%, followed by a slightly higher growth rate of 5.1% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 5.4% in the first half and remain relatively moderate at 6.4% in the second half. In the first half (H1) the sector witnessed a decrease of 40 BPS while in the second half (H2), the business witnessed an increase of 20 BPS.
The Role in Enhancing Livestock Health and Productivity
In response to the worldwide increase in protein demand, incorporating these molecules into animal feed has become strategic. As consumers all over the world reach out for richer proteins, pressure on animal husbandry rises thereby pushing for increased productivity rates alongside better health outcomes.
These dietary supplements are acknowledged for supporting immune function and gut health among livestock when used as nucleotides. For adequate protein supply requirements today this nutrition intervention represents an important aspect of enhancing animal welfare; lowering the incidence of diseases and optimizing growth rates thus making it necessary for improved health status.
Consequently, it is no longer just a trend but rather a necessity in modern animal agriculture that calls for the inclusion of these molecules into feed formulations representing a shift towards scientific knowledge-based farming practices driven by health considerations than before. Doing so assures the industry’s continuous expansion with global food securing maintained potential.
The Trend of Supplementation
Increasingly, these molecules are being seen as key types of diets, especially for their impact on immunity and gut health. This is an emerging trend in the ecosystem where aging individuals are becoming increasingly conscious about staying healthy through dieting. As people take responsibility for their health, they need more supplements that focus on cellular support such as these molecules.
These supplements are perceived to be a natural way of boosting the body’s immune system and general well-being, which agrees with the current shift towards preventable or holistic healthcare. Their supplementation is consistent with this wider move toward non-pharmaceutical nutrition-oriented ways of improving health and longevity.
Flavor Enhancement in the Food Industry
In flavor enhancement in the food industry, these molecules play important roles and hence act as flavor enhancers especially due to their umami qualities among other reasons.
This “umami” taste is sought after by many different cultures, particularly those in emerging economies that have been consuming more processed foods over time. In addition, as these countries develop so does the middle class which then demands food options that are more varied and tastier.
By enriching flavors, these molecules fulfill this need thereby becoming functional ingredients in a range of processed foods including snacks among others. Their role in the food industry is not just about taste but also about meeting consumer expectations for quality and variety. Therefore, there has been a significant rise in sales making them an essential component in the expansion of the global sector for food.
Principal Consultant
Global sales increased at a CAGR of 4.9% from 2019 to 2023. For the next ten years (2024 to 2034), projections are that expenditure will rise at 6.1% CAGR.
Between 2019 and 2023, technological advancements were made regarding the synthesis of these molecules along with extraction using various methods. This led to efficient manufacturing and this molecule, thus making them cost-effective.
This enhanced their applications in the pharmaceutical industry, research labs, and food processing factories. Further development of such technologies has the potential to bolster growth in sales by allowing for new applications and lowering production costs.
This period witnessed significant advances in healthcare with these molecules emerging as key in developing new treatments, especially for viral infections, and cancer, among others. It is further suggested that the need for efficient therapeutic drugs shall remain persistent or even increase since more research is targeting genetic sicknesses and personalized drug therapies which are primarily reliant on these molecules.
Similarly, the need for efficient therapies will continue to be a concern for as long as there is an increased understanding of genetic diseases and personalized medicine which heavily relies on these molecules.
Emerging territories are experiencing rising affluence, thus leading to a rise in demand for processed foods and pharmaceuticals. The shift in demography created new opportunities for products thereby boosting overall sales.
The industry structure of this specific industry segment can be evaluated by considering hierarchical structure, reflecting stratification according to their shares, geographical presence all over the world, and product portfolios as well.
Tier 1 companies are market leaders that have extensive global operations, substantial R&D investment, and a wide range of products. They generally possess strong brands such that they become major suppliers of different categories of these molecules within various applications.
These firms drive innovations as well as set industry standards such as Thermo Fisher Scientific Inc., and Merck KGaA owing to their broad offerings while being at the forefront of technologies related to their synthesis.
Tier two corporations have a considerable presence in the business concentrating on particular regions or product lines. They spend less on R&D than tier-one companies do. These organizations are competitive and may specialize in certain segments of the industry like pharmaceuticals or diagnostics.
Tier three organizations are normally small players that cater to niche segments or local zones. They may give more focused goods or services but hardly influence the global ecosystem. These businesses contribute to diversification and innovation at the industry level on a smaller scale. For instance, TriLink BioTechnologies specializes in custom Nucleic Acid synthesis for research and therapeutic applications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The following table shows the estimated growth rates of the top three territories. India and China are set to exhibit application, recording CAGRs of 10.4% and 8.9%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 5.6% |
| Germany | 5.5% |
| India | 10.4% |
| China | 8.9% |
| Japan | 7.0% |
This sector in the United States is projected to exhibit a CAGR of 5.6% during the assessment period. By 2034, revenue from the sales of this sector in the country is expected to reach USD 350.8 million.
Several factors unique to the USA market dynamics and research landscape underlie this increase in sales. These molecules are vital for genetic research, diagnostics, as well as treatments hence there is a need for constant supply given the fact that the USA is a world leader in biomedical research and pharmaceutical development. The presence of major pharmaceutical companies and research institutions drives demand.
Also, the use of these molecules’ supplementation by the USA animal feed industry to enhance livestock health is compliant with the country's high meat consumption levels and efficient agricultural practices. These factors coupled with United State’s developments in technology associated with the syntheses have triggered increased sales within this category in the general marketplace.
The demand in Germany is calculated to rise at a value CAGR of 5.5% during the forecast period (2024 to 2034). By 2034, Germany is expected to account for 5.5% of sales in the world.
Research and development is a major focus in Germany, especially in the field of biotechnology and pharmaceuticals, which has seen increased demand as key reagents in various molecular and genetic research applications. Germany’s leading pharmaceutical firms and research institutions also provide an enabling environment for the market growth of the manufacturers.
Moreover, its advanced food industry is constantly looking for new flavors and health benefits thus driving further increases in these molecules’ use as flavor enhancers and functional ingredients. Health consciousness in the country has also created huge demands for dietary supplements such as those containing these molecules amongst others.
The utilization in China is projected to increase at a value CAGR of 8.9% over the next ten years. By 2034, the size is forecasted to reach USD 106.9 Million, with China expected to account for a share of 8.9% globally.
China’s economic and scientific conditions have made it an exceptional site where the country’s sales of these molecules have experienced significant growth.
Large-scale genomic initiatives by China are among the factors behind this trend. Similarly, this growth conforms to the expansion of the Chinese food processing industry through functional foods that appeal to increasingly health-minded consumers including those featuring high levels of natural molecules. This is boosted further by a growing middle class with increasing disposable incomes along with a sense of healthy living.
Moreover, modernizing traditional medicine with an emphasis on TCM presents another opportunity for using these molecules while searching for new drugs; hence it leads to a wider distribution network for these molecules across China. Besides that, China's livestock sector adapted its animal feed practices toward administering more additives that can enhance meat quality.
| Segment | Diagnostics Research (By Applications) |
|---|---|
| Value Share (2024) | 62.6% |
Sales of fungicides-based seed treatment are projected to register a CAGR of 13.4% from 2024 to 2034. Fungicides as a microbial treatment offer an excellent method to prevent fungus-borne diseases in plants, which significantly impact the quality and crop yield.
The main driver of the need for these molecules is diagnostics research as it plays a critical role in advancing medical science today. Nucleic acids are crucial components used in different diagnostic purposes such as polymerase chain reaction (PCR) techniques used worldwide in identifying genetic diseases or infection-causing organisms including cancerous cells.
It is worth noting that better results can be obtained due to higher quality standards set by each company regarding their products during labeling processes with tagging kits used such as TaqMan technology. In conclusion, the significance of these molecule-based diagnostics will expand in line with personalized healthcare resulting increase in this segment’s size.
Global healthcare systems focusing on detection methods that can identify diseases at an early stage as well as targeted therapies will fuel the above trend.
| Segment | TaqMan allelic discrimination (By Technology) |
|---|---|
| Value Share (2024) | 46.8% |
TaqMan Allelic Discrimination technology has played a significant role in driving growth within the market. It is considered so vital because it helps genotype by detecting specific sequences of DNA and subsequently identifying certain genetic variations among individuals. The application of Single Nucleotide Polymorphism (SNP) genotyping using these kits is common for research and disease diagnosis processes since it is highly sensitive and efficient.
As a result, there has been an increased demand for high-quality molecules required during assay development in these tests across both clinical centers and laboratories.
The growing practice of personalized medicine as well as population genetics studies have increased reliance on the use of the TaqMan technique thus expanding sales, particularly for genomic analyses done at large. For instance, this ability explains why such systems are being adopted by many farmers globally to increase crop production unlike before.
Innovation and strategic initiatives characterize competition in the market. Manufacturers aim to achieve better results through advanced synthesis techniques that require fewer inputs and lower costs. Such companies commonly collaborate with research institutions to gain access to state-of-the-art scientific developments.
Emerging markets therefore provide a major ground where players can expand their businesses by finding new clients/markets having also entered into other strategies meant to improve supply chain resistance while maintaining customers’ loyalty and reliability respectively; hence enabling them to acquire differentiating factors that would promote their sales volumes further strengthening their positions globally in terms of powerfulness inside this business sector.
For instance
As per application, the industry has been categorized into Pharmaceuticals, Food & Beverage Additives, Diagnostics Research, Animal Feed Additives, and Others.
This segment is further categorized into TaqMan allelic discrimination, Gene chips & microarrays, SNP by pyrosequencing, and Others.
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
The global industry is estimated at a value of USD 672.5 million in 2024.
Sales increased at 4.9% CAGR between 2019 and 2023.
Nanjing Bio Together Co., Ltd., Affymetrix Inc., DSM Nutritional Products Ltd., F. Hoffmann-La Roche Ltd., ThermoFisher Scientific Inc., CJ CheilJedang Corporation, Agilent Technologies Inc., PR omega Corporation, Biorigin and Ohly GmbH are some of the leading players in this business.
The North American territory is projected to hold a revenue share of 32.8% over the forecast period.
The industry is projected to grow at a forecast CAGR of 6.1% from 2024 to 2034.
1. Executive Summary 2. Industry Introduction, Including Taxonomy and Market Definition 3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 7.1. Pharmaceuticals 7.2. Diagnostics Research 7.3. Food & Beverage Additive 7.4. Animal Feed Additive 7.5. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Technology 8.1. TaqMan allelic discrimination 8.2. Gene chips & microarrays 8.3. SNP by pyrosequencing 8.4. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. East Asia 9.6. South Asia and Pacific 9.7. Middle East and Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Category A, Category B, and Category C for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Nanjing Bio Together Co., Ltd. 19.2. Affymetrix Inc. 19.3. DSM Nutritional Products Ltd. 19.4. F. Hoffmann-La Roche Ltd. 19.5. ThermoFisher Scientific Inc. 19.6. CJ CheilJedang Corporation 19.7. Agilent Technologies Inc. 19.8. PR omega Corporation 19.9. Biorigin 19.10. Ohly GmbH 19.11. Star Lake Bioscience Co. 19.12. NuEra Nutrition 19.13. Lallemand Inc.
Explore Food and Beverage Insights
View Reports
Nucleotide Market
